Thema: US4131971040
HRMY, US4131971040
deal-4131445.jpg - Foto: THN
Harmony Biosciences stock faces earnings test on November 4
Harmony Biosciences stock heads into its third-quarter report on November 4. Management will discuss the results before U.S. trading begins.
ad-hoc-news.de, heute 00:43 Uhr
HRMY, US4131971040
Harmony Biosciences names Anastasiou CEO: Ladenburg targets ...
WAKIX revenue hit USD 261.28 million in the second quarter, up 30.30 percent year over year. Harmony Biosciences stock has USD 1.00 billion guidance.
ad-hoc-news.de, 16.10.26 03:50 Uhr
Harmony, Biosciences
Harmony Biosciences Gains Investor Confidence Through Pipeline ...
Harmony Biosciences Holdings US4131971040
boerse-global.de, 18.12.25 10:53 Uhr
Harmony, Biosciences
Harmony Biosciences: Strong Fundamentals Meet Market Skepticism ...
